Valeant: Paulson & Co. Puts (a Bit More) Money Where its Mouth is

The hedge fund increased its stake in Valeant Pharmaceuticals and changed its position to 'active' after John Paulson was voted onto its Board as director last week.

Continue reading at Barron's - Focus on Funds →